Delivery Order SPE2DB22D2206-SPE2DB25FFV74

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $5,475.69 with a completion date of January 9, 2025. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary...
This contract award, valued at $6,214.03, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,627.76 firm fixed-price delivery order is for the supply of 4566963200 units of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $32,814.98 for MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 11, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $2,304.73 with Amerisourcebergen Drug Corp as the prime contractor. The contract is for the supply of MESTINON 180 MG TIMESPAN medication, with a completion date of November 19, 2024. It is a Firm Fixed Price contract, with no set-aside designation indicated. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,740.10, is for the delivery of Mestinon 180 mg Timespan medication. It is a firm fixed-price delivery order contract with a completion date of February 26, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,307.02 Firm Fixed Price delivery order is for the supply of MESTINON 180 MG TIMESPAN pharmaceutical products. The award is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $23,645.38 firm fixed-price delivery order is for MESTINON 180 MG TIMESPAN UU 30S, a medication product. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $4,336.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Mestinon 60 mg tablets, a medication used to treat myasthenia gravis. The contract has a firm fixed price and an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of Mestinon 180 mg Timespan medication to support federal healthcare programs. The $5,021.88 firm fixed-price contract has a completion date of February 19, 2025 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFV74
    Delivery Order

This federal contract award, valued at $12,756.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 27, 2025.

The contract covers the procurement of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

The contract award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen is a for-profit corporate entity registered in the System for Award Management (SAM.gov) since 2002, specializing in the distribution of a wide range of pharmaceutical and medical products to various federal agencies, including the DLA and the Department of Justice.

Generated 5/28/25, 11:08 AM